Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageThe Cigna Group®, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company.
In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR
Business segments
Q2 2026 · $66.13BThe company’s own SEC segment disclosure.
- Network Pharmacy$33.33B50%
- Home Delivery And Specialty$20.44B31%
- Service$4.37B7%
- Service Fees And Other$3.96B6%
- Other Pharmacy$3.72B6%
- Service Other$315.0M0%
Cigna (CI) reported revenue of $71.7B in Q2 2026 (quarter ended Jun 30, 2026), up 6.7% from the same quarter a year earlier. That came with a gross margin of 21% and net income of $1.88B (2.6% of revenue). For the full year FY2025, revenue was $274.9B (+11% year on year) and net income $6.29B. Its largest product in Q2 2026 was Network Pharmacy at $33.3B, 50% of the disclosed total, ahead of Home Delivery And Specialty at 31%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Healthcare
Ranks #182 of 345 by Smart Score